Impact of Breathing Exercises and Meditation on Quality of Life in Dry Eye Disease Patients: A Pilot Study
Primary Purpose
Depression, Quality of Life, Dry Eye
Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
SKY + ASTM + usual care
Usual care
Sponsored by
About this trial
This is an interventional supportive care trial for Depression
Eligibility Criteria
Inclusion Criteria:
- dry eye disease suspects or have mild to severe dry eye disease
- at least between 18 to 80 years of age
- deemed competent such as no language issues or communication barriers, no self-reported or physician diagnosed mental health disorder besides having depressive and anxiety symptoms
- have sufficient hearing to be able to follow verbal instructions and able to sit without physical discomfort for 30 minutes
- willing and able to attend 3 initial SKY and 4 initial ASTM training sessions
- willing to dedicate 20 minutes per day for SKY and 20 minutes twice per day to ASTM practice at their own home.
Exclusion Criteria:
- actively suicidal as per self-report (or score on CES-D) or on assessment by the physician
- they are currently participating in other similar studies
- currently practicing any type of formal meditation techniques regularly
- unable or unwilling to answer survey questions.
Sites / Locations
- St. Joseph's Hospital, Ivey Eye Institute
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
SKY + ASTM + usual care
Usual Care
Arm Description
Sudarshan Kriya Yoga (SKY) followed by Automatic Self Transcending Meditation (ASTM) plus usual care
Treatment as usual
Outcomes
Primary Outcome Measures
Change in Health Related Quality of Life (HRQoL)
Health Related Quality of LIfe (HRQoL) is an essential measure of quality of life related to health. HRQoL will be measured using time trade-off (TTO) questionnaire. HRQoL varies between 0 and 1 where the score of 1 represents perfect health and 0 represents death.
Secondary Outcome Measures
Visual Function Score
Visual related quality of life measured using National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25). The most widely used instrument in vision-related functioning is the NEI VFQ-25. It was designed specifically for a clinical setting and consists of 12 domains: general health, general vision, visual pain, near activities, distance activities, social functioning, mental health, role difficulties, dependency, driving, colour vision and peripheral vision. The shorter 25-item version questionnaire is widely used in different groups of patients and shown to be internally consistent, reproducible and responsive in glaucoma patients. The NEI VFQ-25 scores have a closer relationship to clinical outcomes, in comparison to generic instruments. The scores range from 0 to 100 where higher score represents better vision related quality of life.
Depression
Center for Epidemiologic Studies Depression Scale (CES-D) will be used to measure depression. It is one of the most common validated tools used to measure depression in research to identify depressive symptoms. Additionally, it is a brief standardized valid tool for assessing depressive symptoms. Possible range of scores is zero to 60, with the higher scores indicating the presence of more depressive symptoms.
State and Trait Anxiety
State-Trait Anxiety Inventory (STAI)
Sleep Quality
Pittsburgh Sleep Quality Index (PSQI)
Community Integration
The community integration questionnaire (CIQ) was used to provide a quantitative indicator for the level of social support and ability to perform appropriate roles at home and within the community. The CIQ contains 15-items and uses behavioural items of integration to achieve better reliability. The total CIQ score ranges from 0 to 29, with a higher score representing a higher level of social support and complete community integration.
Canadian Dry Eye Assessment
Canadian Dry Eye Assessment
Dry Eye Assessment
Standardized Patient Evaluation of Eye Dryness (SPEED) Questionnaire
Full Information
NCT ID
NCT03345381
First Posted
November 14, 2017
Last Updated
June 14, 2019
Sponsor
Lawson Health Research Institute
1. Study Identification
Unique Protocol Identification Number
NCT03345381
Brief Title
Impact of Breathing Exercises and Meditation on Quality of Life in Dry Eye Disease Patients: A Pilot Study
Official Title
Impact of Breathing Exercises and Meditation on Health-Related Quality of Life in Dry Eye Disease Patients: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2019 (Anticipated)
Primary Completion Date
September 1, 2020 (Anticipated)
Study Completion Date
December 1, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lawson Health Research Institute
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
People staring at computer screens for long hours, blinking less frequently, or having long-term contact lens wear are prone to dry eye disease (DED). DED is a multifactorial disease accompanied by inflammation of the ocular surface. Further, DED may degrade vision and is associated with depression and have an adverse impact on patient's quality of life. Sudarshan Kriya Yoga (SKY) incorporates standardized collection of breathing techniques followed by Automatic Self Transcending Meditation (ASTM) may help reduce stress, depression, and anxiety, enhance quality of life in patients diagnosed with DED. Thus, the investigators will be studying the effect of SKY plus ASTM on quality of life of DED patients. The investigators plan to conduct a single-center pilot RCT. Patients with DED will be randomized to SKY followed by ASTM plus Usual care (UC) or UC alone to assess changes in health-related quality of life (HRQOL). HRQOL is a vital construct focusing on impact of health on quality of life. Along with HRQOL the investigators will measure changes in extent of depression and anxiety. Additionally, majority of current ophthalmic literature describes changes in clinical variables whilst lacking information on HRQOL. Thus, there is a high necessity to assess if there is an association between HRQOL and routinely measured clinical data. Through this study the investigators shall attempt to correlate HRQOL with clinical data.
Detailed Description
Background: Prevalence of dry eye disease (DED) ranges from 3.5% to 33.7% and increase with age. Further, DED is associated with decreased productivity, absenteeism from work, depression, and has an adverse impact on patient's quality of life. Odds of a DED patient suffering from depression is 2.9 and anxiety is 2.8. Yoga - a practice to help improve health and well-being - has also been the subject of clinical studies globally. Two central aspects of yoga practice are physical postures and breathing exercises. These breathing exercises aim to focus the mind, facilitate relaxation and enhance wellness.
Evidence further suggests beneficial effects of a standardized collection of breathing techniques called Sudarshan Kriya Yoga (SKY) on individuals suffering from depression. SKY includes three-stage breathing with Victory breath (slow deep breathing that consists of 4 to 6 breaths per minute), Bellow's breath (forceful rapid deep breathing that consists of 20 to 30 breaths per minute), and a rhythmic breath technique. SKY followed by Automatic Self Transcending Meditation (ASTM) involves breathing exercise followed by meditation. ASTM utilizes a specific sound value mantra to draw attention inward and permit the mind to experience a restful but alert state of consciousness. It helps quiet the mind and induces physiological and mental relaxation whilst the eyes are shut. ASTM may help with depression, anxiety, stress, and may enhance quality of life. Thus, the investigators will be studying the effect of SKY plus ASTM on quality of life of DED patients. Key goal of proposed research is to evaluate HRQOL, depression, anxiety of patients with DED in SKY followed by ASTM and usual care (UC) versus UC alone from baseline to 24 weeks.
Primary Hypothesis: The investigators hypothesize that in patients with dry eye disease in SKY + ASTM + UC may lead to significant improvement in HRQoL compared to UC alone from baseline to 24 weeks.
Secondary Hypotheses: The investigators hypothesize that in patients with DED 1) HRQoL is associated with regularly measured clinical variables 2) SKY + ASTM + UC leads to significant improvement in depression and anxiety symptoms at 24 weeks compared to UC alone.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Quality of Life, Dry Eye, Anxiety, Sleep
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
SKY + ASTM + usual care
Arm Type
Experimental
Arm Description
Sudarshan Kriya Yoga (SKY) followed by Automatic Self Transcending Meditation (ASTM) plus usual care
Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
Treatment as usual
Intervention Type
Other
Intervention Name(s)
SKY + ASTM + usual care
Intervention Description
Sudarshan Kriya Yoga (SKY) followed by Automatic Self Transcending Meditation (ASTM) involves breathing exercise followed by meditation.
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
Treatment as usual
Primary Outcome Measure Information:
Title
Change in Health Related Quality of Life (HRQoL)
Description
Health Related Quality of LIfe (HRQoL) is an essential measure of quality of life related to health. HRQoL will be measured using time trade-off (TTO) questionnaire. HRQoL varies between 0 and 1 where the score of 1 represents perfect health and 0 represents death.
Time Frame
Up to 24 weeks
Secondary Outcome Measure Information:
Title
Visual Function Score
Description
Visual related quality of life measured using National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25). The most widely used instrument in vision-related functioning is the NEI VFQ-25. It was designed specifically for a clinical setting and consists of 12 domains: general health, general vision, visual pain, near activities, distance activities, social functioning, mental health, role difficulties, dependency, driving, colour vision and peripheral vision. The shorter 25-item version questionnaire is widely used in different groups of patients and shown to be internally consistent, reproducible and responsive in glaucoma patients. The NEI VFQ-25 scores have a closer relationship to clinical outcomes, in comparison to generic instruments. The scores range from 0 to 100 where higher score represents better vision related quality of life.
Time Frame
Up to 24 weeks
Title
Depression
Description
Center for Epidemiologic Studies Depression Scale (CES-D) will be used to measure depression. It is one of the most common validated tools used to measure depression in research to identify depressive symptoms. Additionally, it is a brief standardized valid tool for assessing depressive symptoms. Possible range of scores is zero to 60, with the higher scores indicating the presence of more depressive symptoms.
Time Frame
Up to 24 weeks
Title
State and Trait Anxiety
Description
State-Trait Anxiety Inventory (STAI)
Time Frame
Up to 24 weeks
Title
Sleep Quality
Description
Pittsburgh Sleep Quality Index (PSQI)
Time Frame
Up to 24 weeks
Title
Community Integration
Description
The community integration questionnaire (CIQ) was used to provide a quantitative indicator for the level of social support and ability to perform appropriate roles at home and within the community. The CIQ contains 15-items and uses behavioural items of integration to achieve better reliability. The total CIQ score ranges from 0 to 29, with a higher score representing a higher level of social support and complete community integration.
Time Frame
Up to 24 weeks
Title
Canadian Dry Eye Assessment
Description
Canadian Dry Eye Assessment
Time Frame
Up to 24 weeks
Title
Dry Eye Assessment
Description
Standardized Patient Evaluation of Eye Dryness (SPEED) Questionnaire
Time Frame
Up to 24 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
dry eye disease suspects or have mild to severe dry eye disease
at least between 18 to 80 years of age
deemed competent such as no language issues or communication barriers, no self-reported or physician diagnosed mental health disorder besides having depressive and anxiety symptoms
have sufficient hearing to be able to follow verbal instructions and able to sit without physical discomfort for 30 minutes
willing and able to attend 3 initial SKY and 4 initial ASTM training sessions
willing to dedicate 20 minutes per day for SKY and 20 minutes twice per day to ASTM practice at their own home.
Exclusion Criteria:
actively suicidal as per self-report (or score on CES-D) or on assessment by the physician
they are currently participating in other similar studies
currently practicing any type of formal meditation techniques regularly
unable or unwilling to answer survey questions.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Monali Malvankar
Phone
5196858500
Ext
61288
Email
monali.malvankar@sjhc.london.on.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Monali Malvankar
Organizational Affiliation
University of Western Ontario, Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Joseph's Hospital, Ivey Eye Institute
City
London
State/Province
Ontario
ZIP/Postal Code
N6G0H8
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
De-identified IPD collected in this study will not be available to other researchers (e.g. outside the primary research group). Because the primary research group has the necessary expertise to conduct analysis and do not need any outside help.
Citations:
PubMed Identifier
9402817
Citation
Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997 Dec;124(6):723-8. doi: 10.1016/s0002-9394(14)71688-5.
Results Reference
background
PubMed Identifier
19506195
Citation
Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol. 2009 Jun;127(6):763-8. doi: 10.1001/archophthalmol.2009.103.
Results Reference
background
PubMed Identifier
12888056
Citation
Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003 Aug;136(2):318-26. doi: 10.1016/s0002-9394(03)00218-6.
Results Reference
background
PubMed Identifier
21045640
Citation
Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea. 2011 Apr;30(4):379-87. doi: 10.1097/ICO.0b013e3181f7f363.
Results Reference
background
PubMed Identifier
27518547
Citation
Wan KH, Chen LJ, Young AL. Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond). 2016 Dec;30(12):1558-1567. doi: 10.1038/eye.2016.186. Epub 2016 Aug 12.
Results Reference
background
PubMed Identifier
24626068
Citation
Elder C, Nidich S, Moriarty F, Nidich R. Effect of transcendental meditation on employee stress, depression, and burnout: a randomized controlled study. Perm J. 2014 Winter;18(1):19-23. doi: 10.7812/TPP/13-102.
Results Reference
background
Citation
Burns JL, Lee RM, Brown LJ. The effect of meditation on self-reported measures of stress, anxiety, depression, and perfectionism in a college population. Journal of College Psychotherapy 25(2): 132-144, 2011.
Results Reference
background
Learn more about this trial
Impact of Breathing Exercises and Meditation on Quality of Life in Dry Eye Disease Patients: A Pilot Study
We'll reach out to this number within 24 hrs